Brief: Esperion Therapeutics Q1 Basic EPS USD 0.36
07/05/2024 11:00
May 07 (Reuters) - Esperion Therapeutics Q1 net income USD 61.022 million. * Q1 operating expenses USD 65.466 million * Q1 operating income USD 72.269 million * Q1 product sales USD 24.756 million
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi